Skip to main content
. 2022 Jan 28;23:83. doi: 10.1186/s13063-021-05983-2
Title {1} Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a randomized, 2-parallel-group, evaluator blinded, superiority trial
Trial registration {2a and 2b}. Clinicaltrials.gov registration: NCT03437772 (first posted: February 19, 2018). ClinicalTrials.Gov trial registry meets the WHO registry network criteria. WHO items are available at the registration link.
Protocol version {3} Version 3.0 of this protocol was approved on 09/30/2019. Recruitment began on February 19th, 2018.
Funding {4} Research grant by the French Government (“Programme Hospitalier de Recherche Clinique”)
Author details {5a}

Laetitia Crouzet, MSc. a, Anne Gramond, MD, a, Carey Suehs, PhD, b, Pascale Fabbro-Peray, MD, PhD, b, Mocrane Abbar, MD, PhD, a, Jorge Lopez-Castroman, MD, PhD, a,c,d.

a Department of Psychiatry, Nimes University Hospital, Nimes, France

b Department of biostatistics, epidemiology, public health and medical information, Nimes University Hospital, Nimes, France

c IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France

d CIBERSAM, Spain

Name and contact information for the trial sponsor {5b} Nimes University Hospital, Department of Clinical Research, Partnerships and Medical Projects, email: drc@chu-nimes.fr
Role of sponsor {5c} Funder and sponsor had no involvement in the design, organization, analysis or preparation for publication of the study, and no authority over any of these activities.